ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
96 912,39
-0,30%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Castle Biosciences Inc (CSTL) Cours

Castle Biosciences Inc

Castle Biosciences Inc (CSTL)

NASDAQ
27,53
0,44
(1,62%)
Fermé 22 Décembre 10:00PM
Retardé de 15 minutes
27,5305
0,0005
(0,00%)
Après les heures de négociation: 1:59AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
27,53
Prix Achat
27,50
Prix Vente
45,00
Volume échangé
382 571
26,58 Fourchette du Jour 27,99
16,965 Plage de 52 semaines 35,6973
Cap du marché
771,041M
Clôture Veille
27,09
Ouverture
26,58
Dernière Transaction
264
@
27.53
(priorref)
Dernière heure de transaction
Volume financier
US$ 10 325 510
VWAP
26,9898
Volume moyen (3 m)
382 382
Actions en circulation
28 007 301
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-13,41
Bénéfice par action (BPA)
-2,05
Chiffre d'affairess
219,79M
Bénéfice net
-57,47M

À propos de Castle Biosciences Inc

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more

Secteur
Medical Laboratories
Industrie
Medical Laboratories
Site Web
www.castlebiosciences.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Castle Biosciences Inc est coté dans le secteur Medical Laboratories de la NASDAQ avec le ticker CSTL. Le dernier cours de clôture d'Castle Biosciences était de US$27,09. Au cours de la dernière année, les actions de Castle Biosciences ont été négociées dans une fourchette de prix de US$ 16,965 à US$ 35,6973.

Castle Biosciences compte actuellement 28 007 301 actions en circulation. La capitalisation boursière d'Castle Biosciences est de US$758,72 million. Castle Biosciences a un ratio cours/bénéfice (ratio PE) de -13.41.

CSTL Dernières nouvelles

Plus de nouvelles

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on Dec. 13, 2024, the Compensation Committee of its...

19 Décembre 2024
Business Wire

Independent Systematic Review and Meta-Analysis Attests to the Significant Risk Stratification Provided by Castle Biosciences’ DecisionDx®-Melanoma Test, Contributing to Personalized Management of Patients with Melanoma

This recently published meta-analysis encompasses 13 peer-reviewed publications involving thousands of patients and affirms the powerful risk stratification provided by DecisionDx-Melanoma and...

12 Décembre 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

11 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 Décembre 2024
Edgar (US Regulatory)

Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a...

20 Novembre 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

19 Novembre 2024
Edgar (US Regulatory)

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year

Castle also earns national recognition through three additional Top Workplaces Culture Excellence Awards — Employee Appreciation, Employee Well-Being and Professional Development Castle...

19 Novembre 2024
Business Wire

Form 144 - Report of proposed sale of securities

14 Novembre 2024
Edgar (US Regulatory)

Castle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx®-Melanoma and MyPath® Melanoma at the American Society of Dermatopathology 61st Annual Meeting

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new data highlighting the clinical performance of its...

08 Novembre 2024
Business Wire
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.58-5.427688079729.1129.7226.326205727.86116047CS
4-1.71-5.8481532147729.2432.626.330743429.94131307CS
12-0.44-1.5731140507727.9735.697326.338238231.20071577CS
265.4324.570135746622.135.697316.96539704427.65245573CS
526.5731.345419847320.9635.697316.96532003625.61151392CS
156-13.28-32.541043861840.8148.49.260131295623.36573638CS
2600.331.2132352941227.2107.699.260127606733.81984275CS

CSTL - Frequently Asked Questions (FAQ)

What is the current Castle Biosciences share price?
The current share price of Castle Biosciences is US$ 27,53
How many Castle Biosciences shares are in issue?
Castle Biosciences has 28 007 301 shares in issue
What is the market cap of Castle Biosciences?
The market capitalisation of Castle Biosciences is USD 758,72M
What is the 1 year trading range for Castle Biosciences share price?
Castle Biosciences has traded in the range of US$ 16,965 to US$ 35,6973 during the past year
What is the PE ratio of Castle Biosciences?
The price to earnings ratio of Castle Biosciences is -13,41
What is the cash to sales ratio of Castle Biosciences?
The cash to sales ratio of Castle Biosciences is 3,51
What is the reporting currency for Castle Biosciences?
Castle Biosciences reports financial results in USD
What is the latest annual turnover for Castle Biosciences?
The latest annual turnover of Castle Biosciences is USD 219,79M
What is the latest annual profit for Castle Biosciences?
The latest annual profit of Castle Biosciences is USD -57,47M
What is the registered address of Castle Biosciences?
The registered address for Castle Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Castle Biosciences website address?
The website address for Castle Biosciences is www.castlebiosciences.com
Which industry sector does Castle Biosciences operate in?
Castle Biosciences operates in the MEDICAL LABORATORIES sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CSTL
Castle Biosciences
BIT
I06807
Intesa Sanpaolo
BIT
F22592
Vontobel Financial Produ...
BIT
F14972
Vontobel Financial Produ...
BIT
SPX
ETF
BIT
3NVD
ETP
AMEX
PEXL
Pacer US Export Leaders ...
BIT
NSCIT0053230
Italian Republic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés